Arrowhead Pharmaceuticals

The latest news about Arrowhead Pharmaceuticals: headlines, AI summaries and the full story from every source.

• Arrowhead Pharmaceuticals Director Sells $1 Million Worth of Shares Motley Fool · September 6, 2026, 21:55 UTC
• Arrowhead Pharmaceuticals' Plozasiran Could Drive Stock Re-rating Yahoo Finance · August 28, 2026, 22:26 UTC
• Arrowhead Pharmaceuticals (ARWR) Reaches Five-Year High as Plozasiran Nears sNDA Submission Yahoo Finance · July 22, 2026, 19:05 UTC